Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.
| Market Capitalization | $74.5711 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.299 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.1 |
| EBITDA | -13,138 |
| Profit Margin | -0.6579 |
| Operating Margin TTM | -0.6846 |
| Return on Assets TTM | -0.1681 |
| Return on Equity TTM | -0.2876 |
| Revenue TTM | 21,360 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2012-06-30 | 220 | 525 | ||
| 2013-06-30 | 257 | 398 | ||
| 2014-06-30 | 684 | 607 | 685.831 | 2,527.389 |
| 2015-06-30 | 1,043.269 | 395.146 | 648.123 | 3,754.782 |
| 2016-06-30 | 1,825.018 | 461.53 | 1,363.488 | 5,921.508 |
| 2017-06-30 | 2,037.659 | 602.422 | 1,435.237 | 6,380.665 |
| 2018-06-30 | 2,840.115 | 999.699 | 1,840.416 | 7,477.322 |
| 2019-06-30 | 4,865.908 | 1,686.153 | 3,179.755 | 8,937.549 |
| 2020-06-30 | 11,263 | 4,305 | 6,958 | 11,921 |
| 2021-06-30 | 28,284 | 9,804 | 18,480 | 17,123 |
| 2022-06-30 | 35,421 | 11,989 | 23,432 | 20,567 |
| 2023-06-30 | 21,360 | 7,996 | 13,364 | 28,110 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2013-06-30 | 147 | 915 | 4,231 | 3,924 | 17,892 | |
| 2014-06-30 | 15,420.707 | 16,547.714 | 370.475 | 39,391.69 | ||
| 2015-06-30 | 5,461.686 | 7,800.112 | 743.143 | 32,501.357 | ||
| 2016-06-30 | 2,564.254 | 5,963.164 | 1,283.459 | 32,547.402 | ||
| 2017-06-30 | 13,192.96 | 17,157.213 | 1,189.801 | 0 | 46,777.792 | |
| 2018-06-30 | 8,954.775 | 14,608.521 | 1,209.465 | 0 | 46,777.792 | |
| 2019-06-30 | 6,311.555 | 12,130.036 | 1,560.937 | 0 | 47,027.99 | |
| 2020-06-30 | 31,176 | 49,715 | 3,786 | 313 | 84,013 | |
| 2021-06-30 | 30,121 | 54,047 | 4,707 | 334 | 84,164 | |
| 2022-06-30 | 36,897 | 59,654 | 4,852 | 33 | 84,428 | |
| 2023-06-30 | 16,349 | 49,078 | 6,164 | 0 | 84,438 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2012-06-30 | ||||||
| 2013-06-30 | ||||||
| 2014-06-30 | -1,728.487 | -1,354.737 | 1,705.234 | 1,852.707 | ||
| 2015-06-30 | -2,659.12 | -2,795.14 | 3,608.979 | 1,852.707 | 5,461.686 | |
| 2016-06-30 | -3,026.598 | -2,572.31 | -2,897.432 | 5,461.686 | 2,564.254 | |
| 2017-06-30 | -3,188.342 | -2,571.868 | 10,628.706 | 2,564.254 | 13,192.96 | |
| 2018-06-30 | -3,253.809 | -3,693.561 | -4,238.185 | 13,192.96 | 8,954.775 | |
| 2019-06-30 | -3,491.994 | -2,268.979 | -2,643.22 | 8,954.775 | 6,311.555 | |
| 2020-06-30 | -2,086 | -9,494 | 24,864 | 6,312 | 31,176 | |
| 2021-06-30 | 1,756 | 4,195 | -1,055 | 31,176 | 30,121 | |
| 2022-06-30 | 3,063 | 4,679 | 6,776 | 30,121 | 36,897 | |
| 2023-06-30 | -14,052 | -12,451 | -20,548 | 36,897 | 16,349 |